| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 0.7 | 0.4 | 2.6 | 0.5 | 2.0 | |
| 0.7 | 0.7 | 0.9 | 0.9 | 2.0 | |
| 1.4 | 1.2 | 3.5 | 1.4 | 3.9 | |
Expenses | |||||
| 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | |
| −0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.8 | 0.9 | 1.6 | 1.6 | 1.7 | |
| 0.6 | 0.7 | 0.9 | 0.9 | 0.7 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 1.1 | 1.3 | 1.6 | 1.4 | 1.7 | |
| 2.6 | 3.0 | 4.2 | 4.0 | 4.3 | |
| −1.2 | −1.8 | −0.6 | −2.6 | −1.6 | |
| −1.3 | −1.8 | −0.7 | −2.6 | −1.6 | |
Profit | |||||
| −1.2 | −1.8 | −0.7 | −2.6 | −0.4 | |
| −3.4 | −3.4 | 0.0 | 0.0 | 0.0 | |
| −4.6 | −5.2 | −0.7 | −2.6 | −0.4 | |
| −4.6 | −5.2 | −0.7 | −2.6 | −0.4 | |
| −4.6 | −5.2 | −0.7 | −2.6 | −0.4 | |
| −0.1 | −0.1 | 0.1 | 0.5 | 0.0 | |
| −4.6 | −5.3 | −0.7 | −2.0 | −0.3 | |
Per share | |||||
| −₹2.28 | −₹2.58 | −₹0.36 | −₹1.29 | −₹0.19 | |
| −₹2.28 | −₹2.58 | −₹0.36 | −₹1.29 | −₹0.19 | |
Other comprehensive income — detail | |||||
| −0.1 | −0.1 | 0.1 | — | — | |
| −0.1 | −0.1 | 0.1 | 0.5 | 0.0 | |
Per share — as-filed variants | |||||
| −₹2.28 | −₹2.58 | −₹0.36 | −₹1.29 | −₹0.19 | |
| −₹2.28 | −₹2.58 | −₹0.36 | −₹1.29 | −₹0.19 | |
Derived — gross profit (revenue − materials − purchases − Δ inventories) | |||||
| 0.7 | — | — | 0.4 | 1.8 | |
| 91.1% | — | — | 93.7% | 91.6% | |
Adjusted (ex-exceptional items) — derived | |||||
| −1.2 | −1.8 | −0.7 | −2.6 | −0.4 | |
| −3.4 | −3.4 | 0.0 | 0.0 | 0.0 | |
| −1.2 | −1.8 | −0.7 | −2.6 | −0.4 | |
| −₹0.59 | −₹0.90 | −₹0.36 | −₹1.29 | −₹0.19 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 2.0 | 0.5 | 2.6 | 0.4 | 0.7 | |
| Other Income | 2.0 | 0.9 | 0.9 | 0.7 | 0.7 | |
| Total Income | 3.9 | 1.4 | 3.5 | 1.2 | 1.4 | |
| Expenses | ||||||
| + Cost of Materials Consumed | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | |
| + Changes in Inventories | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| + Employee Benefit Expense | 1.7 | 1.6 | 1.6 | 0.9 | 0.8 | |
| + Finance Costs | 0.7 | 0.9 | 0.9 | 0.7 | 0.6 | |
| + Depreciation & Amortisation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| + Other Expenses | 1.7 | 1.4 | 1.6 | 1.3 | 1.1 | |
| Total Expenses | 4.3 | 4.0 | 4.2 | 3.0 | 2.6 | |
| EBITDA | -1.6 | -2.6 | -0.6 | -1.8 | -1.2 | |
| EBIT | -1.6 | -2.6 | -0.7 | -1.8 | -1.3 | |
| Profit | ||||||
| PBT before Exceptional Items | -0.4 | -2.6 | -0.7 | -1.8 | -1.2 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | -3.4 | -3.4 | |
| Pretax Income | -0.4 | -2.6 | -0.7 | -5.2 | -4.6 | |
| Net Income | -0.4 | -2.6 | -0.7 | -5.2 | -4.6 | |
| + Net Income — Continuing Ops | -0.4 | -2.6 | -0.7 | -5.2 | -4.6 | |
| + Other Comprehensive Income | 0.0 | 0.5 | 0.1 | -0.1 | -0.1 | |
| Total Comprehensive Income | -0.3 | -2.0 | -0.7 | -5.3 | -4.6 | |
| Per Share | ||||||
| Basic EPS | -0.19 | -1.29 | -0.36 | -2.58 | -2.28 | |
| Diluted EPS | -0.19 | -1.29 | -0.36 | -2.58 | -2.28 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | — | — | 0.1 | -0.1 | -0.1 | |
| + Items NOT to be Reclassified to P&L | 0.0 | 0.5 | 0.1 | -0.1 | -0.1 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | -0.19 | -1.29 | -0.36 | -2.58 | -2.28 | |
| Diluted EPS — Continuing Operations | -0.19 | -1.29 | -0.36 | -2.58 | -2.28 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 1.8 | 0.4 | — | — | 0.7 | |
| Gross Margin % | 91.57 | 93.67 | — | — | 91.10 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | -0.4 | -2.6 | -0.7 | -1.8 | -1.2 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | -3.4 | -3.4 | |
| Net Income Adj (tax-effected) | -0.4 | -2.6 | -0.7 | -1.8 | -1.2 | |
| EPS Adj | -0.19 | -1.29 | -0.36 | -0.90 | -0.59 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
| Paid Up Equity Capital | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | |